PMC:7405836 / 125230-125390 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1099","span":{"begin":48,"end":56},"obj":"Disease"},{"id":"T1100","span":{"begin":143,"end":147},"obj":"Disease"}],"attributes":[{"id":"A1099","pred":"mondo_id","subj":"T1099","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A1100","pred":"mondo_id","subj":"T1100","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"esigning and developing potent vaccines against COVID-19 (274).\n\nPREVENTION, CONTROL, AND MANAGEMENT\nIn contrast to their response to the 2002 SARS outbreak, Ch"}

{"project":"LitCovid-sentences","denotations":[{"id":"T841","span":{"begin":65,"end":100},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"esigning and developing potent vaccines against COVID-19 (274).\n\nPREVENTION, CONTROL, AND MANAGEMENT\nIn contrast to their response to the 2002 SARS outbreak, Ch"}

{"project":"LitCovid-PubTator","denotations":[{"id":"3403","span":{"begin":48,"end":56},"obj":"Disease"}],"attributes":[{"id":"A3403","pred":"tao:has_database_id","subj":"3403","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"esigning and developing potent vaccines against COVID-19 (274).\n\nPREVENTION, CONTROL, AND MANAGEMENT\nIn contrast to their response to the 2002 SARS outbreak, Ch"}